Continuous Glucose Monitoring (CGM) for Type 2 Diabetes: Should It Be the Standard? Abstract Continuous glucose monitoring (CGM) has evolved into one of the most notable innovations in modern diabetes care. While its benefits are well established in type 1 diabetes, growing evidence suggests
Internal Medicine
GLP-1 Agonists for NASH Treatment: New Clinical Evidence Reveals Surprising Results
The Role of Plant-Based Diets in Slowing Chronic Kidney Disease Progression: An Analytical Review
The Role of Plant-Based Diets in Slowing Chronic Kidney Disease Progression: An Analytical Review Abstract Background:Chronic kidney disease (CKD) affects more than 10% of the global population and is increasingly recognized as a critical public health challenge. Its rising prevalence is largely attributed to
Endocrine Disruptors and Fertility: What Should Endocrinologists Be Advising?
Endocrine Disruptors and Fertility: What Should Endocrinologists Be Advising? Abstract Endocrine-disrupting chemicals (EDCs) have emerged as a notable concern in reproductive health, with increasing evidence linking exposure to reduced fertility in both men and women. These compounds, which include a broad spectrum of
Autoimmunity and COVID Vaccines: Risk of Flares or Protective Benefits? A Comprehensive Analysis for Academic and Industry Experts
Autoimmunity and COVID Vaccines: Risk of Flares or Protective Benefits? A Comprehensive Analysis for Academic and Industry Experts Abstract The link between getting a COVID-19 vaccine and having an autoimmune disease is an intricate blend of immunology, public health, and clinical practice. This analytical review
Giant Cell Arteritis and the Rapid Rise of Tocilizumab: Are Steroids Obsolete?
Giant Cell Arteritis and the Rapid Rise of Tocilizumab: Are Steroids Obsolete? Abstract Giant cell arteritis (GCA) is the most common form of primary systemic vasculitis in adults over 50 years of age and represents a major cause of morbidity, particularly when diagnosis and treatment are delayed. Traditionally, management
The “Pre-Pre-Diabetes” Zone: Are We Overdiagnosing Glycemic Risk?
The “Pre-Pre-Diabetes” Zone: Are We Overdiagnosing Glycemic Risk? Check back later for a possible video summary. Abstract Recent advancements in the understanding of glycemic dysregulation have led to more sensitive criteria for diagnosing prediabetes. As a result, growing concern has emerged regarding
De-prescribing in Older Adults: Why “Less is More” is Easier Said Than Done
Iron Study Interpretation: Why Traditional Tests Miss Functional Deficiency
Reevaluating the Annual ECG: Screening Tool or Waste of Resources?
